Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Eileen Maunsell
CONTACT
Shuichi Iino
CONTACT
Lead
Sumitomo Pharma America, Inc.
Phase 1/2, global, multicenter, open-label, first-in-human, clinical study to evaluate the safety, tolerability, pharmacokinetics and preliminary antitumor activity of SMP-3124
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted